As of the most recent data (March 2025), TSVT shows a operating income of $-60M. That compares with $-230M in the prior-year period — up 74.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TSVT's operating income is now $-60M (was $-230M) — a 74.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 2seventy bio is outperforming or lagging.

Tracking TSVT's operating income over time shows whether 2seventy bio is scaling, shrinking, or reshaping that part of the business. The current reading is $-60M That compares with $-230M in the prior-year period — up 74.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has 2seventy bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-60M) with ownership activity and broader fundamentals.